As the global economy mends, the 2021 growth of Cefuroxim will have significant change from previous year. According to our (LP Information) latest study, the global Cefuroxim market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cefuroxim market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Cefuroxim market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cefuroxim market, reaching US$ million by the year 2028. As for the Europe Cefuroxim landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cefuroxim players cover Apotex, Esseti Farmaceutici, GSK, and Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefuroxim market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injection
Tablets
Capsule
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Respiratory Tract Infection
Otolaryngological Infection
Urinary Tract Infection
Skin And Soft Tissue Infections
Bone And Joint Infections
Gonorrhea
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Apotex
Esseti Farmaceutici
GSK
Lilly
Medochemie
Northeast Pharmaceutical
NCPC
Nanchang Lijian Pharmaceutical
Sichuan Pharmaceutical
Shandong Runze Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Guangdong Bozhou Pharmaceutical
Guangdong Jincheng Jinsu Pharmaceutical
Guangzhou Baiyunshan Tianxin Pharmaceutical
Guangxi Kelun Pharmaceutical
Yuekang Pharmaceutical Group
Shantou Jinshi Injection
Zhejiang Yatai Pharmaceutical
Shenzhen Xinlitai Pharmaceutical
Shenzhen Huarun Jiuxin Pharmaceutical
Zhuhai Union Pharmaceutical
Ruiyang Pharmaceutical
Fujian Fukang Pharmaceutical
Suzhou Erye Pharmaceutical
furen Pharmaceutical Group
Chongqing Kerui Pharmaceutical Group
Shaanxi Xidunsi Pharmaceutical
Qilu Pharmaceutical
Shandong Zibo Xinda Pharmaceutical
Guangzhou Nanxin Pharmaceutical